Related references
Note: Only part of the references are listed.The use of animal models in diabetes research
Aileen J. F. King
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Finding a Target for Resveratrol
Ruth I. Tennen et al.
CELL (2012)
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Sung-Jun Park et al.
CELL (2012)
Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents
Wonyoung Kang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Sensing of energy and nutrients by AMP-activated protein kinase
D. Grahame Hardie
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Anti-diabetic effects of resveratrol
Tomasz Szkudelski et al.
RESVERATROL AND HEALTH (2011)
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
Pal Brasnyo et al.
BRITISH JOURNAL OF NUTRITION (2011)
Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation
Ana Planavila et al.
CARDIOVASCULAR RESEARCH (2011)
Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic β-cells
Miki Minakawa et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2011)
Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling
Russell A. Miller et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Long-term adaptation of global transcription and metabolism in the liver of high-fat diet-fed C57BL/6J mice
Gyeong-Min Do et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Resveratrol and health - A comprehensive review of human clinical trials
James M. Smoliga et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism
Su-Kyung Shin et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome?
Jean-Louis Beaudeux et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2010)
AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol
Jee-Hyun Um et al.
DIABETES (2010)
Ameliorative Potential of Resveratrol on Proinflammatory Cytokines, Hyperglycemia Mediated Oxidative Stress, and Pancreatic β-Cell Dysfunction in Streptozotocin-Nicotinamide-Induced Diabetic Rats
P. Palsamy et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Resveratrol bioavailability and toxicity in humans
Charles-Henry Cottart et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats
Leonor Rivera et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity
P. Kar et al.
DIABETIC MEDICINE (2009)
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
Jing Shang et al.
ACTA PHARMACOLOGICA SINICA (2008)
Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK
Danna M. Breen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways
Jen-Ying Deng et al.
DIABETES (2008)
Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice
Kwon-Il Seo et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Combretastatin A-4 activates AMP-activated protein kinase and improves glucose metabolism in db/db mice
Fang Zhang et al.
PHARMACOLOGICAL RESEARCH (2008)
The anti-obesity effect of the palatinose-based formula Inslow is likely due to an increase in the hepatic PPAR-α and adipocyte PPAR-γ gene expressions
Kaoru Matsuo et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2007)
Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice
Mengwei Zang et al.
DIABETES (2006)
Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha
Myeong Jin Yoon et al.
DIABETES (2006)
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
DS Cai et al.
NATURE MEDICINE (2005)
Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy
G Walldius et al.
JOURNAL OF INTERNAL MEDICINE (2004)
The biology of peroxisome proliferator -: Activated receptors -: Relationship with lipid metabolism and insulin sensitivity
P Ferré
DIABETES (2004)
Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice
H Inoue et al.
NEUROSCIENCE LETTERS (2003)
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
T Yamauchi et al.
NATURE MEDICINE (2002)
Mechanism for peroxisome proliferator-activated receptor-α activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes
T Nakatani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle
JFP Wojtaszewski et al.
DIABETES (2002)
Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia
C Weyer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus - A randomized controlled trial
V Fonseca et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism
P She et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
